U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07411105) titled 'Cognition in Older Adults With Cancer Receiving Systemic Anti-Cancer Therapy' on Jan. 06.
Brief Summary: The majority of cancer diagnoses occur in adults age 65 years and over. This population is also rapidly expanding. There is a growing need for increased understanding about the potential impact of various newer therapies on common geriatric impairments in this group.
The aim of this study is to examine how feasible it is to carry out a study of cognitive function in older adults (age 65+) who are newly commencing anti-cancer treatments, specifically 'immune checkpoint inhibitor' therapy, over time. Participants in the study unde...